Amyloid Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Amyloid stocks.

Amyloid Stocks Recent News

Date Stock Title
May 19 LLY SA Roundtable: Are Eli Lilly and Novo Nordisk overvalued?
May 19 LLY Is Amgen a Threat to Eli Lilly in This Billion-Dollar Market?
May 17 LLY Top Research Reports for Microsoft, Eli Lilly & Costco
May 17 IONS Ionis, Biogen Down on Ending Development of ALS Drug
May 17 LLY 4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly
May 17 ABUS Update: Arbutus Biopharma Urged to Stop Share Issuances, Explore Alternatives for Hepatitis B Program
May 17 LLY Eli Lilly's (LLY) Efsitora Matches Daily Insulins in A1C Control
May 17 ANVS Amgen's (AMGN) Tarlatamab Receives FDA Approval for SCLC
May 17 LLY Pharma Stock Roundup: BAYRY's Q1 Earnings, JNJ's New Buyout, Pipeline Updates
May 17 ABUS Arbutus Biopharma Urged to Stop Share Issuances, Explore Alternatives for Hepatitis B Program
May 17 IONS Ionis (IONS), Biogen Down on Ending Development of ALS Drug
May 17 ABUS Whitefort Capital Publishes Open Letter to Arbutus Biopharma Shareholders Outlining Paths to Maximize Value
May 17 LLY Meet the GLP-1 Drug That Could Be the Biggest Concern for Eli Lilly and Novo Nordisk
May 17 LLY Eli Lilly’s efsitora alfa shows promise in Phase III T2D trials
May 17 LLY Zacks Investment Ideas feature highlights: Apple, Eli Lilly and Crocs
May 16 LLY 3 Stocks to Buy Following Positive Earnings Results
May 16 IONS Biogen also drops collaboration with Ionis on Angelman syndrome candidate
May 16 ANVS Kodiak (KOD) Q1 Loss Narrower Than Expected, Pipeline in Focus
May 16 LLY 3 Drug Stocks to Watch on Raised 2024 Earnings & Sales Guidance
May 16 LLY Roche’s New Weight-Loss Data Shows Lilly Isn’t Unbeatable in Obesity
Amyloid

Amyloids are aggregates of proteins characterised by a fibrillar morphology of 7–13 nm in diameter, a β-sheet secondary structure (known as cross-β) and ability to be stained by particular dyes, such as Congo red. In the human body, amyloids have been linked to the development of various diseases. Pathogenic amyloids form when previously healthy proteins lose their normal structure and physiological functions (misfolding) and form fibrous deposits in plaques around cells which can disrupt the healthy function of tissues and organs.
Such amyloids have been associated with (but not necessarily as the cause of) more than 50 human diseases, known as amyloidosis, and may play a role in some neurodegenerative disorders. Some of these diseases are mainly sporadic and only a few cases are familial. Others are only familial. Some are iatrogenic as they result from medical treatment. One amyloid protein is infectious and is called prion in which the infectious form can act as a template to convert other non-infectious proteins into infectious form. Amyloids may also have normal biological functions; for example, in the formation of fimbriae in some genera of bacteria, transmission of epigenetic traits in fungi, as well as pigment deposition and hormone release in humans.Amyloids have been known to arise from many different proteins. These polypeptide chains generally form β-sheet structures that aggregate into long fibers; however, identical polypeptides can fold into multiple distinct amyloid conformations. The diversity of the conformations may have led to different forms of the prion diseases.

Browse All Tags